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Background-—The ART (Arterial Revascularization Trial) showed no difference in survival at 10 years between patients assigned to
the single versus bilateral internal thoracic artery grafting strategies. This finding is in contrast with the results of most
observational studies, where the use of 2 internal thoracic arteries has been associated with improved survival.
Methods and Results-—We selected propensity-matched studies from the most comprehensive observational meta-analysis on the
long-term outcomes of patients receiving 1 versus 2 internal thoracic arteries. Individual participant survival data from each study
and the ART were reconstructed using an iterative algorithm that was applied to solve the Kaplan-Meier equations. The
reconstructed individual participant survival data were aggregated to obtain combined survival curves and Cox regression hazard
ratios with 95% CIs. Individual participant survival data were obtained from 14 matched observational studies (24 123 patients)
and the ART. The 10-year survival of the control group of ART was significantly higher than that of the matched observational
studies (hazard ratio, 0.86; 95% CI, 0.80–0.93). The 10-year survival of the experimental group of ART was significantly lower than
that of the bilateral internal thoracic artery group of the observational studies (hazard ratio, 1.11; 95% CI, 1.03–1.20).
Conclusions-—Both the improved outcome of the control arm and the lower beneficial effect of the intervention had played a role in
the difference between observational evidence and ART. ( J Am Heart Assoc. 2019;8:e014638. DOI: 10.1161/JAHA.119.
014638.)
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D isagreement between observational and randomizedevidence is common in medicine and is mainly caused
by selection and publication bias and hidden confounders in
observational studies. However, because of their high com-
plexity and costs, large-scale randomized trials are lacking for
most of our research questions and, currently, <12% of the
clinical guidelines in the cardiovascular field are based on the
results of randomized studies.1
The ART (Arterial Revascularization Trial) is the only large
randomized trial comparing the clinical outcomes of patients
submitted to coronary artery bypass grafting using 2 versus 1
internal thoracic artery (ITA).2 In ART, no difference in survival
at 10 years was found between patients assigned to the 2
revascularization strategies. This finding is in contrast with the
results of most observational studies, where the use of 2 ITAs
has generally been associated with improved survival.3 Of
note, on the basis of the observational evidence, the use of 2
ITAs is a class IIA recommendation in current guidelines.4
The suggested explanations for the contradiction between
ART and the observational evidence are as follows: (1) the
improved outcomes of the control arm (because of the
Hawthorne effect, the high rate of use of the radial artery, or
the high compliance with guideline-directed secondary pre-
vention) or (2) the reduced effect of the experimental
intervention (because of the diluting effects of high crossover
rate from experimental to control group, issues in the delivery
of the intervention, or lack of true biological effect).5
Identification of the main mechanism may not only shed light
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on the use of bilateral ITAs but also on the methodological
differences between randomized and observational evidence,
and it may inform decision making for guidelines and
recommendations development and health policy strategies.
We compared the outcome of the experimental and control
groups in ART with the correspondent groups in observational
studies. As a summary of the observational evidence, we
selected the most comprehensive observational meta-analysis
on the long-term outcomes of patients receiving 1 versus 2
ITAs3 and included only the propensity-matched studies
(considered the highest quality of observational evidence).
Accordingly, individual participant survival data from 14
matched observational studies (24 123 patients) and the
ART were reconstructed using an iterative algorithm that was
applied to solve the Kaplan-Meier equations. The details of
patients in the individual studies are summarized in the
Table.6–19 The reconstructed individual participant survival
data were aggregated to obtain combined survival curves and
Cox regression hazard ratios (HRs) with 95% CIs.20
We found that the 10-year survival of the control group of
ART was significantly higher than that of the matched
observational studies (HR, 0.86; 95% CI, 0.80–0.93; Figure
[left]). The 10-year survival of the experimental group of ART
was significantly lower than that of the bilateral ITA group of
the observational studies (HR, 1.11; 95% CI, 1.03–1.20). The
HRs for the comparisons between the 2 groups in ART and in
the matched observational studies were 0.96 (95% CI, 0.79–
1.17) and 0.65 (95% CI, 0.62–0.69), respectively. The HR for
the comparison between the experimental group in ART and
the control arm of the observational studies was 0.89 (95% CI,
0.85–0.94). Similar results were obtained in a sensitivity
analysis considering ART as-treated results (comparing
patients who received multiple arterial grafts with those
who received a single arterial graft; Figure [right]).
The disagreement between the results of ART and of the
observational evidence has been intensely debated. The
neutral results of ART have been attributed to either the
improved outcome of the control group or the lower
effectiveness of the intervention.5 The first had been
explained by the frequent (21.8%) use of the radial artery in
the single ITA group and/or the high compliance with
guideline-directed medical therapy. The latter has been
attributed to the high (13.9%) crossover rate from the
experimental to the control group and to the limited
experience of some of the ART surgeons.
Our results suggest that both explanations may be true,
although the better outcome of the control arm is slightly
predominant. The differences compared with the observa-
tional evidence were similar for the intention-to-treat and as-
treated analyses, suggesting that hidden confounders and
Figure. Reconstructed Kaplan-Meier curves from individual participant-derived data from propensity score–matched observational studies and
the ART (Arterial Revascularization Trial) intention-to-treat (left) and as-treated analysis (right). The hazard ratios for the as-treated analysis were
as follows: single internal thoracic artery (SITA)–ART vs SITA-observational (OBS), 0.84 (95% CI, 0.74–0.95); multiple arterial grafts (MAG)–ART
vs bilateral internal thoracic artery (BITA)–OBS, 1.19 (95% CI, 1.05–1.35); MAG-ART vs SITA-ART, 0.78 (95% CI, 0.67–0.92); and MAG-ART vs
SITA-OBS, 0.67 (95% CI, 0.59–0.75).
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treatment allocation bias in observational studies persist even
after propensity matching, heavily disfavoring the control
treatment group.3 Implications of our work may extend
beyond coronary surgery and inform other efforts of compar-
ative risk-benefit analysis of complex medical or surgical
cardiovascular interventions.
This analysis has limitations and must be considered
exploratory. Meta-analyses of observational studies have bias
and confounders. Important data (eg, surgeon experience and
details of secondary prevention) were not reported by most
observational studies. In addition, digitalization and recon-
struction of survival curves, although widely accepted,20 has
intrinsic limitations related to the quality of the initial input
and the level of information provided in the original publica-
tion. Finally, in the absence of individual patient data, the role
of nonproportional hazards and censoring patterns on the
outcomes could not be determined.
In conclusion, this meta-analytic exploration of the dis-
agreement between the results of ART and the previous
observational evidence suggests that both the improved
outcome of the control arm and the lower beneficial effect of
the intervention had played a role and confirm the strong bias
and confounders inherent even in propensity-matched obser-
vational studies. Large randomized trials are key in answering
important clinical questions and should be prioritized by
health bodies and funding agencies.
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None.
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